Published in Invest Ophthalmol Vis Sci on June 01, 2006
Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res (2010) 1.20
Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci (2012) 1.07
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog Retin Eye Res (2013) 1.06
Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye. Adv Healthc Mater (2014) 0.92
Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy. J Ophthalmol (2011) 0.89
Transscleral iontophoretic and intravitreal delivery of a macromolecule: study of ocular distribution in vivo and postmortem with MRI. Exp Eye Res (2008) 0.89
Transscleral diffusion of ethacrynic acid and sodium fluorescein. Mol Vis (2007) 0.88
Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles. Eur J Pharm Biopharm (2015) 0.85
Intravitreal devices for the treatment of vitreous inflammation. Mediators Inflamm (2012) 0.83
Unraveling the equine lymphocyte proteome: differential septin 7 expression associates with immune cells in equine recurrent uveitis. PLoS One (2014) 0.80
Thickness and Closure Kinetics of the Suprachoroidal Space Following Microneedle Injection of Liquid Formulations. Invest Ophthalmol Vis Sci (2017) 0.76
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science (2002) 19.77
Topographical and temporal diversity of the human skin microbiome. Science (2009) 15.96
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol (2005) 12.88
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol (2005) 9.72
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res (2012) 3.71
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation (2008) 3.63
Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol (2011) 3.63
Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2009) 3.54
Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 3.04
Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis (2002) 2.80
Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci (2011) 2.53
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J Clin Microbiol (2010) 2.43
Selective loss of imprinting in the placenta following preimplantation development in culture. Development (2004) 2.23
A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum (2005) 2.20
Angiophagy prevents early embolus washout but recanalizes microvessels through embolus extravasation. Sci Transl Med (2014) 2.11
Procedural volume and structure of interventional pulmonary fellowships: a survey of fellows and fellowship program directors. Chest (2013) 2.06
The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J (2004) 2.04
Stability of alemtuzumab solutions at room temperature. Am J Health Syst Pharm (2013) 2.03
The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results. Ophthalmology (2004) 2.01
Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung. Clin Lung Cancer (2012) 1.93
Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2011) 1.92
Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci (2005) 1.92
Interface fluid syndrome in human eye bank corneas after LASIK: causes and pathogenesis. Ophthalmology (2007) 1.89
Increased endothelial cell density in the paracentral and peripheral regions of the human cornea. Am J Ophthalmol (2003) 1.79
Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis. J Immunother (2004) 1.77
Reprogramming of primordial germ cells begins before migration into the genital ridge, making these cells inadequate donors for reproductive cloning. Proc Natl Acad Sci U S A (2003) 1.73
Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc Natl Acad Sci U S A (2011) 1.72
Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea (2008) 1.68
A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathog (2006) 1.66
Neural basis of irony comprehension in children with autism: the role of prosody and context. Brain (2006) 1.63
Ocular drug delivery. Expert Opin Drug Deliv (2006) 1.61
Reading affect in the face and voice: neural correlates of interpreting communicative intent in children and adolescents with autism spectrum disorders. Arch Gen Psychiatry (2007) 1.60
Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in Marine recruits: a cluster-randomized, double-blind, controlled effectiveness trial. Infect Control Hosp Epidemiol (2010) 1.60
Depth-dependent cohesive tensile strength in human donor corneas: implications for refractive surgery. J Refract Surg (2008) 1.58
Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol (2004) 1.57
Toxic anterior segment syndrome. J Cataract Refract Surg (2006) 1.53
West Nile virus: pathogenesis and therapeutic options. Ann Intern Med (2004) 1.51
Prevalence of posterior subcapsular cataracts in volunteer cytapheresis donors. Transfusion (2010) 1.51
Developmental changes in the neural basis of interpreting communicative intent. Soc Cogn Affect Neurosci (2006) 1.47
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension. Br J Haematol (2005) 1.47
Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest Ophthalmol Vis Sci (2011) 1.46
Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA). Invest Ophthalmol Vis Sci (2009) 1.41
Ultrasound biomicroscopy of the iridocorneal angle of the eye before and after phacoemulsification and intraocular lens implantation in dogs. Am J Vet Res (2008) 1.39
Evaluation of endothelial mucin layer thickness after phacoemulsification with next generation ophthalmic irrigating solution. Cornea (2008) 1.39
Staphylococcus epidermidis pan-genome sequence analysis reveals diversity of skin commensal and hospital infection-associated isolates. Genome Biol (2012) 1.38
Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations. J Refract Surg (2005) 1.33
Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol (2008) 1.33
Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 1.32
The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study. Ophthalmology (2003) 1.30
Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease. Emerg Infect Dis (2010) 1.27
Dissemination of an Enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.26
Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients. Cancer Res (2010) 1.25
The remediation of heavy metals contaminated sediment. J Hazard Mater (2008) 1.25
Age as an independent risk factor for severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2002) 1.23
Enteroaggregative Escherichia coli disrupts epithelial cell tight junctions. Infect Immun (2010) 1.23
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration. AAPS J (2012) 1.22
Corneal ectasia after excimer laser keratorefractive surgery: histopathology, ultrastructure, and pathophysiology. Ophthalmology (2008) 1.22
Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res (2010) 1.20
Biodegradable implants for sustained drug release in the eye. Pharm Res (2010) 1.20
A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Exp Eye Res (2005) 1.18
Histologic, ultrastructural, and immunofluorescent evaluation of human laser-assisted in situ keratomileusis corneal wounds. Arch Ophthalmol (2005) 1.18
Transport barriers in transscleral drug delivery for retinal diseases. Ophthalmic Res (2007) 1.17
Biomechanical and wound healing characteristics of corneas after excimer laser keratorefractive surgery: is there a difference between advanced surface ablation and sub-Bowman's keratomileusis? J Refract Surg (2008) 1.17
Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging. Invest Ophthalmol Vis Sci (2004) 1.17
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci (2010) 1.17
Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology (2005) 1.16
FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye. Mol Vis (2009) 1.16
Gonadotropin-inhibitory hormone neurons interact directly with gonadotropin-releasing hormone-I and -II neurons in European starling brain. Endocrinology (2007) 1.16
Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol Vis (2008) 1.15
Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center. Clin Infect Dis (2009) 1.14
DNA Methylation in Whole Blood: Uses and Challenges. Curr Environ Health Rep (2015) 1.14
The use of semiconductor diode laser for deflation and coagulation of anterior uveal cysts in dogs, cats and horses: a report of 20 cases. Vet Ophthalmol (2004) 1.13
Case of late-onset corneal decompensation after iris-fixated phakic intraocular lens implantation. J Cataract Refract Surg (2009) 1.13
Vitreous VEGF clearance is increased after vitrectomy. Invest Ophthalmol Vis Sci (2009) 1.13
High sensitivity and specificity of acid-fast microscopy for diagnosis of pulmonary tuberculosis in an African population with a high prevalence of human immunodeficiency virus. J Clin Microbiol (2009) 1.12
Evidence suggesting the existence of stem cells for the human corneal endothelium. Mol Vis (2005) 1.12
Selection of strains for quality assessment of the disk induction method for detection of inducible clindamycin resistance in Staphylococci: a CLSI collaborative study. J Clin Microbiol (2005) 1.10
Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2003) 1.10
Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol Vis (2007) 1.10
Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. Am J Ophthalmol (2005) 1.10
Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates. J Clin Microbiol (2006) 1.10
Long-term histopathologic findings in human corneal wounds after refractive surgical procedures. Am J Ophthalmol (2005) 1.08
Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration. Retina (2006) 1.08
Nonlethal oxidant injury to human retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity. Invest Ophthalmol Vis Sci (2005) 1.08
Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res (2011) 1.08
Use of housekeeping gene sequencing for species identification of viridans streptococci. Diagn Microbiol Infect Dis (2005) 1.08
Granulibacter bethesdensis gen. nov., sp. nov., a distinctive pathogenic acetic acid bacterium in the family Acetobacteraceae. Int J Syst Evol Microbiol (2006) 1.07